Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rory Wolfe

Showing results (301-310 of 424) with videos related to

Pageof 43
Sort By:
Trials|April 13, 2016
Aspirin in venous leg ulcer study (ASPiVLU): study protocol for a randomised controlled trialCarolina D Weller, Anna Barker, Ian Darby, et al.
JAMA Network Open|July 25, 2024
Low-Dose Aspirin and Progression of Age-Related Hearing Loss: A Secondary Analysis of the ASPREE Randomized Clinical TrialDavid P Q Clark, Zhen Zhou, Sultana M Hussain, et al.
American Journal of Hypertension|September 14, 2021
Long-Term Blood Pressure Variability and Kidney Function in Participants of the ASPREE TrialMichael E Ernst, Michelle A Fravel, Katherine L Webb, et al.
Contemporary Clinical Trials|August 3, 2020
Cancer history and risk factors in healthy older people enrolling in the ASPREE clinical trialSuzanne G Orchard, Jessica E Lockery, Peter Gibbs, et al.
Circulation. Cardiovascular Quality and Outcomes|April 28, 2025
Performance of the American Heart Association PREVENT Cardiovascular Risk Equations in Older AdultsMichelle A Fravel, Michael E Ernst, Robyn L Woods, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 17, 2022
Effect of Aspirin on CKD Progression in Older Adults: Secondary Analysis From the ASPREE Randomized Clinical TrialKevan R Polkinghorne, James B Wetmore, Le Thi Phuong Thao, et al.
Journal of Alzheimer'S Disease Reports|October 7, 2020
Normative Data for the Symbol Digit Modalities Test in Older White Australians and Americans, African-Americans, and Hispanic/LatinosJoanne Ryan, Robyn L Woods, Carlene J Britt, et al.
General Hospital Psychiatry|September 12, 2017
Psychometric properties of a short form of the Center for Epidemiologic Studies Depression (CES-D-10) scale for screening depressive symptoms in healthy community dwelling older adultsMohammadreza Mohebbi, Van Nguyen, John J McNeil, et al.
The Medical Journal of Australia|July 22, 2008
Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot studyMark R Nelson, Christopher M Reid, David A Ames, et al.
Journal of the American College of Cardiology|September 29, 2022
Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) GenotypesPaul Lacaze, Andrew Bakshi, Moeen Riaz, et al.
Pageof 43

Showing results (301-310 of 424) with videos related to

Sort By:
Pageof 43
Trials|April 13, 2016
Aspirin in venous leg ulcer study (ASPiVLU): study protocol for a randomised controlled trialCarolina D Weller, Anna Barker, Ian Darby, et al.
JAMA Network Open|July 25, 2024
Low-Dose Aspirin and Progression of Age-Related Hearing Loss: A Secondary Analysis of the ASPREE Randomized Clinical TrialDavid P Q Clark, Zhen Zhou, Sultana M Hussain, et al.
American Journal of Hypertension|September 14, 2021
Long-Term Blood Pressure Variability and Kidney Function in Participants of the ASPREE TrialMichael E Ernst, Michelle A Fravel, Katherine L Webb, et al.
Contemporary Clinical Trials|August 3, 2020
Cancer history and risk factors in healthy older people enrolling in the ASPREE clinical trialSuzanne G Orchard, Jessica E Lockery, Peter Gibbs, et al.
Circulation. Cardiovascular Quality and Outcomes|April 28, 2025
Performance of the American Heart Association PREVENT Cardiovascular Risk Equations in Older AdultsMichelle A Fravel, Michael E Ernst, Robyn L Woods, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 17, 2022
Effect of Aspirin on CKD Progression in Older Adults: Secondary Analysis From the ASPREE Randomized Clinical TrialKevan R Polkinghorne, James B Wetmore, Le Thi Phuong Thao, et al.
Journal of Alzheimer'S Disease Reports|October 7, 2020
Normative Data for the Symbol Digit Modalities Test in Older White Australians and Americans, African-Americans, and Hispanic/LatinosJoanne Ryan, Robyn L Woods, Carlene J Britt, et al.
General Hospital Psychiatry|September 12, 2017
Psychometric properties of a short form of the Center for Epidemiologic Studies Depression (CES-D-10) scale for screening depressive symptoms in healthy community dwelling older adultsMohammadreza Mohebbi, Van Nguyen, John J McNeil, et al.
The Medical Journal of Australia|July 22, 2008
Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot studyMark R Nelson, Christopher M Reid, David A Ames, et al.
Journal of the American College of Cardiology|September 29, 2022
Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) GenotypesPaul Lacaze, Andrew Bakshi, Moeen Riaz, et al.
Pageof 43